Loading company…
Orexo develops and commercializes drug delivery technologies, including treatments for opioid use disorder.
Orexo is a pharmaceutical company developing and commercializing drug delivery technologies, including treatments for opioid use disorder and related conditions. Its AmorphOX® powder technology is designed to improve the bioavailability of medicines. Founded in 1995, the company is based in Uppsala, Sweden. In November 2005, it raised SEK 333 million in an IPO, selling 3.7 million shares at SEK 90 apiece on the Stockholm Stock Exchange under the ticker ORX. Nikolaj Sorensen is the CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in